Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

BGIICC 2018 /
Guidelines and genomic factors for endometrial cancer

18th - 19th Jan 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 26.01.18
Views: 802
Rating:

Dr Maia Dzhugashvili - GenesisCare, Spain

Dr Dzhugashvili speaks with ecancer at the 10th BGICC in Cairo about treatment guidelines for women with endometrial cancer.

She outlines treatment sequencing and stratification, leading with surgery followed by adjuvant treatments, depending on the patients risk profile.

Dr Dzhugashvili highlights when vaginal brachytherapy is recommended, and also discusses the PORTEC4 trial investigating genomic factors in endometrial cancer.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence